{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:53:16Z","timestamp":1776415996003,"version":"3.51.2"},"reference-count":85,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T00:00:00Z","timestamp":1702166400000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bpa.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T04:10:02Z","timestamp":1661919002000},"page":"411-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of tranexamic acid in the management of postpartum haemorrhage"],"prefix":"10.1016","volume":"36","author":[{"given":"Anne-Sophie","family":"Bouthors","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sixtine","family":"Gilliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Sentilhes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hennart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Jeanpierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Deneux-Tharaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Lebuffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpa.2022.08.004_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijoa.2010.12.002","article-title":"Standard haemostatic tests following major obstetric haemorrhage","volume":"20","author":"de Lloyd","year":"2011","journal-title":"Int J Obstet Anesth"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ajog.2015.03.054","article-title":"Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management","volume":"213","author":"Erez","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpa.2022.08.004_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/1471-0528.14382","article-title":"Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study","volume":"124","author":"Revert","year":"2017","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/jpm-2016-0238","article-title":"Serum fibrinogen levels could be an index of successful use of balloon tamponade in postpartum hemorrhage","volume":"46","author":"Nakashima","year":"2018","journal-title":"J\u00a0Perinat Med"},{"issue":"2","key":"10.1016\/j.bpa.2022.08.004_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bpa.2022.08.004_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2014-04-567891","article-title":"Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study","volume":"124","author":"Collins","year":"2014","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.bpa.2022.08.004_bib7","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0049-3848(17)30069-5","article-title":"Disseminated intravascular coagulation in pregnancy \u2013 clinical phenotypes and diagnostic scores","volume":"151","author":"Erez","year":"2017","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.bpa.2022.08.004_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.thromres.2009.06.034","article-title":"Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality","volume":"124","author":"Sawamura","year":"2009","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.bpa.2022.08.004_bib9","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.bpa.2022.08.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijoa.2021.102983","article-title":"The incidence, aetiology, and coagulation management of massive postpartum haemorrhage: a two-year national prospective cohort study","volume":"47","author":"Bell","year":"2021","journal-title":"Int J Obstet Anesth"},{"issue":"2","key":"10.1016\/j.bpa.2022.08.004_bib11","doi-asserted-by":"crossref","first-page":"B16","DOI":"10.1016\/j.ajog.2016.03.012","article-title":"Amniotic fluid embolism: diagnosis and management","volume":"215","author":"Pacheco","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00003081-198528010-00003","article-title":"Abruptio placentae with coagulopathy: a rational basis for management","volume":"28","author":"Sher","year":"1985","journal-title":"Clin Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.bpa.2022.08.004_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-0528.2009.02187.x","article-title":"Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry","volume":"116","author":"Huissoud","year":"2009","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1213\/ANE.0b013e3182652a33","article-title":"Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy","volume":"115","author":"Karlsson","year":"2012","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.bpa.2022.08.004_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1213\/ANE.0000000000004422","article-title":"Assessment of coagulation by thromboelastography during ongoing postpartum hemorrhage: a retrospective cohort analysis","volume":"130","author":"Rigouzzo","year":"2020","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.bpa.2022.08.004_bib16","first-page":"112","article-title":"Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage","volume":"17","author":"Mu\u00f1oz","year":"2019","journal-title":"A\u00a0NATA Consensus Statement"},{"issue":"Suppl 1","key":"10.1016\/j.bpa.2022.08.004_bib17","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1111\/jth.12935","article-title":"Basic mechanisms and regulation of fibrinolysis","volume":"13","author":"Longstaff","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bpa.2022.08.004_bib18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/med.21315","article-title":"Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders","volume":"34","author":"Al-Horani","year":"2014","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjh.14255","article-title":"Bleeding related to disturbed fibrinolysis","volume":"175","author":"Kolev","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.bpa.2022.08.004_bib20","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/j.1538-7836.2012.04925.x","article-title":"Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator","volume":"10","author":"Silva","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.bpa.2022.08.004_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00558210","article-title":"Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers","volume":"7","author":"Eriksson","year":"1974","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2022.08.004_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jcp.33.Suppl_14.41","article-title":"Clinical pharmacology of aminocaproic and tranexamic acids","volume":"14","author":"Nilsson","year":"1980","journal-title":"J\u00a0Clin Pathol Suppl (R Coll Pathol)"},{"key":"10.1016\/j.bpa.2022.08.004_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0304-4165(81)90312-3","article-title":"Studies on the mechanism of the antifibrinolytic action of tranexamic acid","volume":"673","author":"Hoylaerts","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bpa.2022.08.004_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00554669","article-title":"Pharmacokinetics and bioavailability of tranexamic acid","volume":"20","author":"Pilbrant","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2022.08.004_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/00365528709089756","article-title":"Clinical pharmacology of tranexamic acid","volume":"137","author":"Astedt","year":"1987","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"5","key":"10.1016\/j.bpa.2022.08.004_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00044011-199510050-00005","article-title":"Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients","volume":"10","author":"Benoni","year":"1995","journal-title":"Clin Drug Investig"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acs.jmedchem.9b01060","article-title":"Fibrinolysis inhibitors: potential drugs for the treatment and prevention of bleeding","volume":"63","author":"Steinmetzer","year":"2020","journal-title":"J\u00a0Med Chem"},{"issue":"6","key":"10.1016\/j.bpa.2022.08.004_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bja.2020.01.020","article-title":"Effect of tranexamic acid by baseline risk of death in acute bleeding patients: a meta-analysis of individual patient-level data from 28 333 patients","volume":"124","author":"Ageron","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2022.08.004_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.bpa.2022.08.004_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/anae.12910","article-title":"The current place of tranexamic acid in the management of bleeding","volume":"70","author":"Hunt","year":"2015","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bpa.2022.08.004_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1503\/cmaj.081109","article-title":"The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis","volume":"180","author":"Henry","year":"2009","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.bpa.2022.08.004_bib32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5223(95)70118-4","article-title":"Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial","volume":"110","author":"Karski","year":"1995","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1749-8090-9-32","article-title":"Factors affecting postoperative blood loss in children undergoing cardiac surgery","volume":"9","author":"Faraoni","year":"2014","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.bpa.2022.08.004_bib34","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00000542-200611000-00026","article-title":"Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery","volume":"105","author":"Zufferey","year":"2006","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.bpa.2022.08.004_bib35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1053\/j.jvca.2013.04.003","article-title":"Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: clinical efficacy and safety","volume":"27","author":"Makhija","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"10.1016\/j.bpa.2022.08.004_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.bpa.2022.08.004_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"10210","key":"10.1016\/j.bpa.2022.08.004_bib38","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"10241","key":"10.1016\/j.bpa.2022.08.004_bib39","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2022.08.004_bib40","first-page":"CD000249","article-title":"Antifibrinolytics for heavy menstrual bleeding","volume":"4","author":"Bryant-Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bpa.2022.08.004_bib42","doi-asserted-by":"crossref","unstructured":"Taeuber I, Weibel S, Herrmann E, et\u00a0al. Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. JAMA Surg. 14 avr 2021;e210884.","DOI":"10.1001\/jamasurg.2021.0884"},{"issue":"6","key":"10.1016\/j.bpa.2022.08.004_bib43","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00228-020-03064-y","article-title":"Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data","volume":"77","author":"St\u00e4mpfli","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2022.08.004_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13613-014-0036-6","article-title":"Postpartum acute renal failure: a multicenter study of risk factors in patients admitted to ICU","volume":"4","author":"Jonard","year":"2014","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2015.11.022","article-title":"Renal cortical necrosis in postpartum hemorrhage: a case series","volume":"68","author":"Frimat","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"suppl_1","key":"10.1016\/j.bpa.2022.08.004_bib46","doi-asserted-by":"crossref","first-page":"i120","DOI":"10.1093\/ndt\/gfy104.FP268","article-title":"Postpartum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers","volume":"33","author":"Jamme","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"10017","key":"10.1016\/j.bpa.2022.08.004_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(15)00838-7","article-title":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group","volume":"387","author":"Alkema","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2022.08.004_bib48","first-page":"230p","year":"2017"},{"key":"10.1016\/j.bpa.2022.08.004_bib49","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/trf.12550","article-title":"Evaluation and management of postpartum hemorrhage: consensus from an international expert panel","volume":"54","author":"Abdul-Kadir","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.bpa.2022.08.004_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.02.023","article-title":"Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines","volume":"213","author":"Dahlke","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpa.2022.08.004_bib51","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/1471-0528.14305","article-title":"Comparison of postpartum haemorrhage guidelines: discrepancies underline our lack of knowledge","volume":"124","author":"Sentilhes","year":"2017","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib52","first-page":"303","article-title":"Should we add tranexamic acid to postpartum haemorrhage protocols after the WOMAN trial publication?","volume":"37","author":"Ducloy-Bouthors","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.bpa.2022.08.004_bib53","first-page":"CD007872","article-title":"Tranexamic acid for preventing postpartum haemorrhage","volume":"7","author":"Novikova","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/1658-354X.121077","article-title":"Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial","volume":"7","author":"Goswami","year":"2013","journal-title":"Saudi J Anaesth"},{"issue":"11","key":"10.1016\/j.bpa.2022.08.004_bib55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.annfar.2014.07.748","article-title":"Efficacy and safety of tranexamic acid administration for the prevention and\/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis","volume":"33","author":"Faraoni","year":"2014","journal-title":"Ann Fr Anesth Reanim"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/bja\/aeu448","article-title":"Tranexamic acid for the prevention and treatment of postpartum haemorrhage","volume":"114","author":"Sentilhes","year":"2015","journal-title":"Br J Anaesth"},{"issue":"8","key":"10.1016\/j.bpa.2022.08.004_bib57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic acid for the prevention of blood loss after vaginal delivery","volume":"379","author":"Sentilhes","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.bpa.2022.08.004_bib58","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2022.08.004_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.06.019","article-title":"Tranexamic acid for the prevention of blood loss after cesarean among women with twins. A secondary analysis of the TRAAP2 randomized clinical trial","author":"Sentilhes","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpa.2022.08.004_bib60","doi-asserted-by":"crossref","unstructured":"Pachedo et\u00a0al. Tranexamic acid for the prevention of obstetrical hemorrhage after cesarean delivery: a randomized controlled trial. SFMP abstract. Am J Obstet Gynecol S779","DOI":"10.1016\/j.ajog.2021.12.020"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib61","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1186\/s13063-018-3081-x","article-title":"Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial","volume":"19","author":"Ker","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.bpa.2022.08.004_bib62","unstructured":"Sentilhes L. L'acide tran\u00e9xamique en pr\u00e9vention de l'h\u00e9morragie du post-partum apr\u00e8s c\u00e9sarienne en cas de placenta pr\u00e6via. Etude contr\u00f4l\u00e9e, en double aveugle, contre placebo, randomis\u00e9e, multicentrique TRAAPrevia Code promoteur: CHUBX 2018\/64"},{"key":"10.1016\/j.bpa.2022.08.004_bib63","unstructured":"WHO recommendations for the prevention and treatment of postpartum hemorrhage. www.who.int\/reproductivehealth\/publications\/maternal_perinatal_health\/9789241548502\/en\/."},{"issue":"5","key":"10.1016\/j.bpa.2022.08.004_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/bja\/aew021","article-title":"Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial","volume":"116","author":"Ducloy-Bouthors","year":"2016","journal-title":"Br J Anaesth"},{"issue":"10084","key":"10.1016\/j.bpa.2022.08.004_bib65","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2022.08.004_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur","year":"2010","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12884-020-03091-8","article-title":"The WOMAN trial: clinical and contextual factors surrounding the deaths of 483 women following post-partum haemorrhage in developing countries","volume":"20","author":"Picetti","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.bpa.2022.08.004_bib68","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/ans.15669","article-title":"How treatment delay may lead to loss of effectiveness of tranexamic acid","volume":"90","author":"Locke","year":"2020","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000000789","article-title":"What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies","volume":"30","author":"Picetti","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib70","doi-asserted-by":"crossref","first-page":"85.e1","DOI":"10.1016\/j.ajog.2020.11.035","article-title":"Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women","volume":"225","author":"Ahmadzia","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpa.2022.08.004_bib71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13063-017-2420-7","article-title":"Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial","volume":"19","author":"Bouthors","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.bpa.2022.08.004_bib72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13063-017-2421-6","article-title":"TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial","volume":"19","author":"Ducloy-Bouthors","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.bpa.2022.08.004_bib73","unstructured":"Ducloy-Bouthors AS, Sixtine Gilliot, Maeva Kyheng et al. Antifibrinolytic dose-response relationship for tranexamic acid in postpartum hemorrhage after caesarean section: the TRACES pharmaco-biological double-blind, placebo-controlled, multicentre dose-ranging study. BJA-D-22-00647 under press."},{"issue":"3","key":"10.1016\/j.bpa.2022.08.004_bib74","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/pharmaceutics14030578","article-title":"Pharmacokinetics of curative tranexamic acid in parturients undergoing cesarean delivery","volume":"14","author":"Gilliot","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bpa.2022.08.004_bib75","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ejps.2020.105486","article-title":"Hypothesis for a partially non urinary elimination of tranexamic acid in haemorrhagic caesarean section: traces pilot pharmacokinetic study: pharmacokinetics of tranexamic acid in obstetrics","volume":"153","author":"Gilliot","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12884-018-1794-1","article-title":"Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage","volume":"18","author":"Roberts","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.bpa.2022.08.004_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12688\/wellcomeopenres.14722.1","article-title":"Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial","volume":"3","author":"Shakur-Still","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"6","key":"10.1016\/j.bpa.2022.08.004_bib78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/anae.14184","article-title":"Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis","volume":"73","author":"Grassin-Delyle","year":"2018","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bpa.2022.08.004_bib79","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1111\/bcp.14767","article-title":"Population pharmacokinetics and pharmacodynamics of tranexamic acid in women undergoing cesarean delivery","volume":"87","author":"Li","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jth.15114","article-title":"Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery","volume":"19","author":"Miszta","year":"2021","journal-title":"J\u00a0Thromb Haemost Doi"},{"key":"10.1016\/j.bpa.2022.08.004_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105893","article-title":"Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers","volume":"164","author":"Kane","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bpa.2022.08.004_bib82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jclinpath-2016-203854","article-title":"An in\u00a0vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis","volume":"70","author":"Godier","year":"2016","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.bpa.2022.08.004_bib83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijoa.2018.08.008","article-title":"Management of postpartum haemorrhage: from research into practice, a narrative review of the literature and the Cardiff experience","volume":"37","author":"Collins","year":"2019","journal-title":"Int J Obstet Anesth"},{"issue":"1","key":"10.1016\/j.bpa.2022.08.004_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijoa.2012.09.008","article-title":"Hyperfibrinolysis diagnosed by rotational thromboelastometry in a case of suspected amniotic fluid embolism","volume":"22","author":"Collins","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.bpa.2022.08.004_bib85","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00404-020-05466-w","article-title":"Amniotic fuid embolism-associated coagulopathy: a single-center observational study","volume":"301","author":"Schr\u00f6der","year":"2020","journal-title":"Arch Gynecol Obstet"}],"container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689622000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689622000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:50:54Z","timestamp":1776412254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689622000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":85,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1521689622000465"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2022.08.004","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of tranexamic acid in the management of postpartum haemorrhage","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}